<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>zjuwhw&#39;s blog</title>
    <description>This is zjuwhw&#39;s personal blog. Powered by Jekyll and Host in Github.
</description>
    <link>zjuwhw.github.io/</link>
    <atom:link href="zjuwhw.github.io/feed.xml" rel="self" type="application/rss+xml"/>
    <pubDate>Thu, 08 Dec 2016 09:34:39 +0800</pubDate>
    <lastBuildDate>Thu, 08 Dec 2016 09:34:39 +0800</lastBuildDate>
    <generator>Jekyll v3.1.2</generator>
    
      <item>
        <title>Eric Lander的MOOC</title>
        <description>&lt;h2 id=&quot;schedular&quot;&gt;Schedular&lt;/h2&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;序号&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;领域&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;具体内容&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;1&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Introduction&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt; &lt;br /&gt;  Medical revolutions in Biology&lt;br /&gt;Biological applications in forensics, history, and agriculture&lt;br /&gt;The diversity of life&lt;br /&gt;An overvie of evolution and a comparison of prokaryotic and eukaryotic cells&lt;br /&gt;The fundamental principles and intellectual framework of biology&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;2&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Biochemistry&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Biochemistry of life&lt;/strong&gt;&lt;br /&gt; Framework, Buchner, and Fractionating life&lt;br /&gt;Molecular composition of cells&lt;br /&gt;Covalent bonds&lt;br /&gt;Non-covalent bonds&lt;br /&gt;Lipids and phospholipids: creating boundaries&lt;br /&gt;High energy molecules: ATP and carbohydrates&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;3&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Proteins and Protein Structure&lt;/strong&gt; &lt;br /&gt; Amazing proteins: primary structure  &lt;br /&gt; Meet the amino acids  &lt;br /&gt; Secondary structure  &lt;br /&gt; Tertiary and quaternary structure&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;4&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Enzymes&lt;/strong&gt; &lt;br /&gt; Design a channel protein &lt;br /&gt; Enzymes and biochemical reactions   &lt;br /&gt; What do enzymes do? &lt;br /&gt;How do enzymes work?  &lt;br /&gt;Influenza virus F tricks of a burglar&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;5&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Pathways: Glycolysis&lt;/strong&gt; &lt;br /&gt; The energetics of pathways   &lt;br /&gt; Logical tricks of pathways  &lt;br /&gt; Glycolysis: a pathway to break down sugar  &lt;br /&gt; Regulation of pathways  &lt;br /&gt; Cellular respiration and fermentation&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;6&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Genetics&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Mendel&lt;/strong&gt;  &lt;br /&gt; Background: Who was Mendel? Why Peas?  &lt;br /&gt; Mendel’s Experiments: controls and crosses  &lt;br /&gt; Definitions  &lt;br /&gt; Multiple traits: Mendel’s second law  &lt;br /&gt; Cytology  &lt;br /&gt; The chromosomal theory of inheritance&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;7&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Rediscovery of Mendel and advances by TH Morgan&lt;/strong&gt; &lt;br /&gt; Meiosis &lt;br /&gt; Fruit flies and linkage  &lt;br /&gt; Linkage Maps  &lt;br /&gt;  Linkage Mapping  &lt;br /&gt;  Sex chromosomes and sex linkage&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;8&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Basics of human genetics&lt;/strong&gt;  &lt;br /&gt; X-linked recessive inheritance   &lt;br /&gt; Autosomal dominant inheritance  &lt;br /&gt; Autosomal recessive inheritance  &lt;br /&gt;  Real human genetics  &lt;br /&gt; Garrod and inborn errors of metabolism&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;9&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Biochemical Genetics&lt;/strong&gt; &lt;br /&gt; Garrod, Beadle, Tatum and the link between genetics and biochemistry  &lt;br /&gt; Yeast as a model organism &lt;br /&gt; How to use genetics to study biochemistry:  A mutant hunt   &lt;br /&gt; Tricks of a mutant hunt &lt;br /&gt; Characterizing mutants: test of dominance &lt;br /&gt; Characterizing mutants: complementation test  &lt;br /&gt; Characterizing mutants: epistasis test&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;10&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Molecular Biology&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;DNA as the hereditary material&lt;/strong&gt;  &lt;br /&gt;  The Transforming principle  &lt;br /&gt;  Structure of DNA: nucleotides and base-pairing  &lt;br /&gt;  Bacterial viruses &lt;br /&gt;  DNA structure, the race&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;11&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;DNA Replication&lt;/strong&gt; &lt;br /&gt; Meselson and Stahl &lt;br /&gt; Details of DNA replication &lt;br /&gt; Additional details of DNA replication: topography and other enzymes  &lt;br /&gt; Additional details of DNA replication: fidelity &lt;br /&gt; Kornberg’s enzyme&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;12&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Central Dogma: Transcription and Translation&lt;/strong&gt; &lt;br /&gt; RNA &lt;br /&gt; Transcription: making RNA copy of DNA  &lt;br /&gt; Translation: making a polypeptide from RNA  &lt;br /&gt; Peering back in time.&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;13&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Variations on the Central Dogma&lt;/strong&gt; &lt;br /&gt; Replication in different organisms  &lt;br /&gt; Transcription in different organisms  &lt;br /&gt; Translation in different organisms&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;14&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;A tale of two genes: β-galactosidase and β-globin&lt;/strong&gt;   &lt;br /&gt;  β-galactosidase in E. coli  &lt;br /&gt;  Lac operon, lactose regulation  &lt;br /&gt;  Lac operon, glucose regulation  &lt;br /&gt;  Hormone receptors in mammals  &lt;br /&gt; β-globin gene structure. &lt;br /&gt;  β-globin mutations  &lt;br /&gt; The β-globin region&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;15&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Recombinant DNA&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Cloning: Purifying a gene&lt;/strong&gt; &lt;br /&gt; Overview  &lt;br /&gt; Cutting and pasting molecules of DNA  &lt;br /&gt; Vectors  &lt;br /&gt; Transformation of host cells   &lt;br /&gt; Selection and creating a library&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;16&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Finding a specific gene in the library&lt;/strong&gt; &lt;br /&gt; Review/Overview &lt;br /&gt; Tricks for cloning  &lt;br /&gt;Different cloning vectors and source DNA  &lt;br /&gt; Finding your gene by complementation&lt;br /&gt; Finding your gene by protein expression&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;17&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Analyzing a gene&lt;/strong&gt; &lt;br /&gt;Gel electrophoresis  &lt;br /&gt;DNA sequencing, the concept &lt;br /&gt;DNA sequencing, implementation &lt;br /&gt;Polymerase Chain Reaction (PCR)&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;18&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Genomics&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Human genome and positional cloning&lt;/strong&gt; &lt;br /&gt; Recombinant DNA review  &lt;br /&gt;Finding your gene: human Mendelian diseases  &lt;br /&gt; Finding markers across the genome for positional cloning   &lt;br /&gt; The Human Genome Project, genome assembly and analysis &lt;br /&gt; Improvements since the Human Genome project  &lt;br /&gt;Improvements in DNA sequencing&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;19&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Secrets of the human genome&lt;/strong&gt; &lt;br /&gt; Tour of the genome: the genomic landscape  &lt;br /&gt; Evolutionary comparison &lt;br /&gt; Evolutionary comparison as a tool for biomedical research  &lt;br /&gt; DNA polymorphisms within humans&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;20&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Observing&lt;/strong&gt;  &lt;br /&gt;DNA polymorphism in medicine: Mendelian disease  &lt;br /&gt; DNA polymorphisms: polygenic disease  3&lt;br /&gt; RNA variation  &lt;br /&gt; Protein localization on the genome&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;21&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Completing the  Triangle&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Perturbing the genome to probe function&lt;/strong&gt; &lt;br /&gt; Adding and subtracting genes  &lt;br /&gt; RNA interference  &lt;br /&gt; Modern genome editing: TALEN proteins and CRSPR&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;22&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Rational Medicine&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Familial hypercholesterolemia&lt;/strong&gt; &lt;br /&gt;Heart disease &lt;br /&gt; Cholesterol &lt;br /&gt; Lipoprotein particles  &lt;br /&gt; Connections to heart disease  &lt;br /&gt;Genetics of cholesterol levels  &lt;br /&gt;Rational therapy for FH heterozygotes  &lt;br /&gt;Modern strategies: PCSK9 and HDL&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;23&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Cancer&lt;/strong&gt;  &lt;br /&gt;  Cancer  &lt;br /&gt;  Regulation of cell growth: growth factors and receptors  &lt;br /&gt;  Regulation of cell growth: Ras &lt;br /&gt;  Regulation of cell growth: Ras signaling  &lt;br /&gt; Mutations that cause cancer &lt;br /&gt;  Anti-cancer therapy&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;24&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;strong&gt;Science and Society&lt;/strong&gt;  &lt;br /&gt;  DNA and law &lt;br /&gt;  Other forensic technologies  &lt;br /&gt; Gene patenting&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
</description>
        <pubDate>Fri, 02 Dec 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/12/02/Eric-Lander-course-schedule.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/12/02/Eric-Lander-course-schedule.html</guid>
        
        <category>mooc</category>
        
        <category>bio</category>
        
        
      </item>
    
      <item>
        <title>癌症里程碑翻译之NCI</title>
        <description>&lt;p&gt;注：本文翻译自美国国立癌症研究院（NCI）的网页&lt;a href=&quot;https://www.cancer.gov/research/progress/250-years-milestones&quot;&gt;《Milestones in Cancer Research and Discovery》&lt;/a&gt;&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;During the past 250 years, we have witnessed many landmark discoveries in our efforts to make progress against cancer, an affliction known to humanity for thousands of years. This timeline shows a few key milestones in the history of cancer research.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;在过去250年中，我们见证了在人类努力对抗癌症，这个人类上千年的灾难，过程中的很多重要的发现。这个时间表列出了很多重要的里程碑。&lt;/p&gt;

&lt;h3 id=&quot;chimney-soot--squamous-cell-carcinoma&quot;&gt;1775年，烟囱灰和鳞状细胞癌（Chimney Soot &amp;amp; Squamous Cell Carcinoma）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Percivall Pott identifies a relationship between exposure to chimney soot and the incidence of squamous cell carcinoma of the scrotum among chimney sweeps. His report is the first to clearly link an environmental exposure to the development of cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;波希瓦·帕特（Percivall Pott）鉴定了烟囱清洁工的阴囊鳞状细胞癌与烟囱灰暴露之间的关系。他的报告首次清晰地关联了环境暴露与癌症发展的关系。&lt;/p&gt;

&lt;h3 id=&quot;inflammation--cancer&quot;&gt;1863年，炎症与癌症（Inflammation &amp;amp; Cancer）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Rudolph Virchow identifies white blood cells (leukocytes) in cancerous tissue, making the first connection between inflammation and cancer. Virchow also coins the term “leukemia” and is the first person to describe the excess number of white blood cells in the blood of patients with this disease.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;鲁道夫·菲尔绍（Rudolph Virchow）鉴定出癌组织中的白细胞，首次明确了炎症与癌症的关系。他也创造了“白血病”这个词，首次描述了在患者的血液存在过量白细胞这一现象。&lt;/p&gt;

&lt;h3 id=&quot;the-first-radical-mastectomy-to-treat-breast-cancer&quot;&gt;1882年，首次使用根除性乳房切除术治疗乳腺癌（The First Radical Mastectomy to Treat Breast Cancer）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;William Halsted performs the first radical mastectomy to treat breast cancer. This surgical procedure remains the standard operation for breast cancer until the latter half of the 20th century.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;威廉·史都华·豪斯泰德（William Halsted）首次做了根除性乳房切除术用来治疗乳腺癌。该手术直到20世纪后叶都是乳腺癌的标准治疗方法。&lt;/p&gt;

&lt;h3 id=&quot;inheritance-of-cancer-risk&quot;&gt;1886年，癌症危险因素的遗传（Inheritance of Cancer Risk）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Brazilian ophthalmologist Hilário de Gouvêa provides the first documented evidence that a susceptibility to cancer can be inherited from a parent to a child. He reports that two of seven children born to a father who was successfully treated for childhood retinoblastoma, a malignant tumor of the eye, also developed the disease.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;巴西的眼科医师Hilário de Gouvêa提供了一个可有文档的证据，癌症的易感性可以从父母遗传给孩子。他报道了一个视网膜母细胞瘤被成功治愈的父亲的7个孩子，其中2个也得了这种病。&lt;/p&gt;

&lt;h3 id=&quot;xthe-first-x-ray&quot;&gt;1895年，首次X射线（The First X-Ray）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Wilhelm Roentgen discovers X-rays. The first X-ray picture is an image of one of his wife’s hands.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;威廉·伦琴（Wilhelm Roentgen）发现了X线。第一张X线图片是他妻子的一只手。&lt;/p&gt;

&lt;h3 id=&quot;radium--polonium&quot;&gt;1898年，镭和钋（Radium &amp;amp; Polonium）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Marie and Pierre Curie discover the radioactive elements radium and polonium. Within a few years, the use of radium in cancer treatment begins.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;居里夫妇发现了放射性的元素镭和钋。之后几年，使用镭来治疗癌症开始了。&lt;/p&gt;

&lt;h3 id=&quot;cancer-tumors--single-cells-with-chromosome-damage&quot;&gt;1902年，癌症与染色体损伤的单细胞（Cancer Tumors &amp;amp; Single Cells with Chromosome Damage）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Theodor Boveri proposes that cancerous tumors arise from single cells that have experienced chromosome damage and suggests that chromosome alterations cause the cells to divide uncontrollably.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;西奥多·博韦里（Theodor Boveri）提出癌症可以从一个染色体算上的单细胞产生，染色体变异可以引起细胞不受控制的分裂。&lt;/p&gt;

&lt;h3 id=&quot;the-first-use-of-radiation-therapy-to-cure-cancer&quot;&gt;1903年，首次使用放疗治疗癌症（The First Use of Radiation Therapy to Cure Cancer）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;S.W. Goldberg and Efim London describe the use of radium to treat two patients with basal cell carcinoma of the skin. The disease was eradicated in both patients.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;S.W. Goldberg and Efim London使用镭去治疗了2个患有基底細胞皮肤癌的病人。疾病在2个病人中被清楚。&lt;/p&gt;

&lt;h3 id=&quot;immune-surveillance&quot;&gt;1909年，免疫监视（Immune Surveillance）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Paul Ehrlich proposes that the immune system usually suppresses tumor formation, a concept that becomes known as the “immune surveillance” hypothesis. This proposal prompts research, which continues today, to harness the power of the immune system to fight cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;保罗·埃尔利希(Paul Ehrlich)提出了“免疫监视”这一概念，指出免疫系统通常是可以抑制肿瘤形成的。这个概念促进的科学研究直到今天还在进行，人们利用免疫系统来对抗癌症。&lt;/p&gt;

&lt;h3 id=&quot;cancer-in-chickens&quot;&gt;1911年，鸡的癌症（Cancer in Chickens）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Peyton Rous discovers a virus that causes cancer in chickens (Rous sarcoma virus), establishing that some cancers are caused by infectious agents.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;裴顿·劳斯(Peyton Rous)发现了一种可以引起鸡得癌症的病毒（劳氏肉瘤病毒），提出了一些癌症是由传染媒介引起的。&lt;/p&gt;

&lt;h3 id=&quot;cancer-in-rabbits&quot;&gt;1915年，兔子的癌症（Cancer in Rabbits）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Katsusaburo Yamagiwa and Koichi Ichakawa induce cancer in rabbits by applying coal tar to their skin, providing experimental proof that chemicals can cause cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;山极胜三郎和市川厚一将煤焦油涂在兔子的皮肤上，诱导兔子患上癌症，为化学物质引起癌症提供了实验证据。&lt;/p&gt;

&lt;h3 id=&quot;the-pap-smear&quot;&gt;1928年，宫颈刮片（The Pap Smear）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;George Papanicolaou discovers that cervical cancer can be detected by examining cells from the vagina under a microscope. This breakthrough leads to the development of the Pap test, which allows abnormal cervical cells to be detected and removed before they become cancerous.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;乔治·帕帕尼古拉乌（George Papanicolaou）发现子宫颈癌可以通过使用显微镜查看阴道的细胞检测到。这个突破性的进展推动了巴氏涂片检查（Pap test）的发展，可以使得异常的子宫颈细胞在他们变得恶性之前被检测和清楚。&lt;/p&gt;

&lt;h3 id=&quot;the-modified-radical-mastectomy-for-breast-cancer&quot;&gt;1932年，改进的根除性乳房切除术（The Modified Radical Mastectomy for Breast Cancer）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;David H. Patey develops the modified radical mastectomy for breast cancer. This surgical procedure is less disfiguring than the radical mastectomy and eventually replaces it as the standard surgical treatment for breast cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;David H. Patey研发了改进版的根除性乳房切除术。手术的过程更少的毁坏形象，进而成为了乳腺癌的标准手术方法。&lt;/p&gt;

&lt;h3 id=&quot;the-national-cancer-institute-nci&quot;&gt;1937年，美国国立癌症研究院（The National Cancer Institute, NCI)&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Legislation signed by President Franklin D. Roosevelt establishes the National Cancer Institute (NCI).&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;美国总统富兰克林·罗切特签署法案，建立了美国国立癌症研究院。&lt;/p&gt;

&lt;h3 id=&quot;breast-sparing-surgery-followed-by-radiation&quot;&gt;1937年，乳房保留手术联合放疗（Breast-Sparing Surgery Followed by Radiation）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Sir Geoffrey Keynes describes the treatment of breast cancer with breast-sparing surgery followed by radiation therapy. After surgery to remove the tumor, long needles containing radium are inserted throughout the affected breast and near the adjacent axillary lymph nodes.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Sir Geoffrey Keynes描述了使用乳房保留手术联合放疗的方法。在手术切除肿瘤后，含有镭的长针会插入到受影响的乳房和附近的腋下的淋巴结。&lt;/p&gt;

&lt;h3 id=&quot;hormonal-therapy&quot;&gt;1941年，激素疗法（Hormonal Therapy）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Charles Huggins discovers that removing the testicles to lower testosterone production or administering estrogens causes prostate tumors to regress. Such hormonal manipulation—more commonly known as hormonal therapy—continues to be a mainstay of prostate cancer treatment.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;查尔斯·布兰顿·哈金斯（harles Huggins）发现降低睾酮产生的睾丸切除，或者是服用雌激素可以使得前列腺癌消退。这样的调节激素的疗法依然是前列腺癌治疗的主流。&lt;/p&gt;

&lt;h3 id=&quot;antimetabolites&quot;&gt;1947年，抗代谢物（Antimetabolites）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Sidney Farber shows that treatment with the antimetabolite drug aminopterin, a derivative of folic acid, induces temporary remissions in children with acute leukemia. Antimetabolite drugs are structurally similar to chemicals needed for important cellular processes, such as DNA synthesis, and cause cell death by blocking those processes.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;西德尼·法伯（Sidney Farber）提出使用抗代谢药物氨基蝶呤（一种叶酸的衍生物）可以诱导儿童的急性白血病暂时缓解。抗代谢药物从结构上与DNA合成等重要细胞过程所需要的化学物类似，从而通过阻断这些过程导致细胞死亡。&lt;/p&gt;

&lt;h3 id=&quot;nitrogen-mustard&quot;&gt;1949年，氮芥（Nitrogen Mustard）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves nitrogen mustard (mechlorethamine) for the treatment of cancer. Nitrogen mustard belongs to a class of drugs called alkylating agents, which kill cells by chemically modifying their DNA.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;美国食品药品管理局（FDA）批准氮芥（二氯甲基二乙胺）治疗癌症。氮芥属于烷化剂的一种，他们可以通过化学上改变DNA来杀死细胞。&lt;/p&gt;

&lt;h3 id=&quot;cigarette-smoking--lung-cancer&quot;&gt;1950年，吸烟与肺癌（Cigarette Smoking &amp;amp; Lung Cancer）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Ernst Wynder, Evarts Graham, and Richard Doll identify cigarette smoking as an important factor in the development of lung cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Ernst Wynder, Evarts Graham, and Richard Doll证明吸烟是肺癌发病的重要因素。&lt;/p&gt;

&lt;h3 id=&quot;the-first-complete-cure-of-a-human-solid-tumor&quot;&gt;1953年，首次完全治愈一个实体瘤（The First Complete Cure of a Human Solid Tumor）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Roy Hertz and Min Chiu Li achieve the first complete cure of a human solid tumor by chemotherapy when they use the drug methotrexate to treat a patient with choriocarcinoma, a rare cancer of the reproductive tissue that mainly affects women.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Roy Hertz和李敏求通过化疗完成了首次实体瘤痊愈。他们使用药物甲氨蝶呤来治疗绒（毛）膜癌患者。其实一种主要发病在女性的生殖组织的罕见癌症。&lt;/p&gt;

&lt;h3 id=&quot;combination-chemotherapy&quot;&gt;1958年，联合化疗（Combination Chemotherapy）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;NCI researchers Emil Frei, Emil Freireich, and James Holland and their colleagues demonstrate that combination chemotherapy with the drugs 6-mercaptopurine and methotrexate can induce partial and complete remissions and prolong survival in children and adults with acute leukemia.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;NCI的研究院Emil Frei、Emil Freireich、James Hollan以及他们的同事证明了6-巯基嘌呤（6-MP）和甲氨蝶呤联合化疗可以使得儿童和成人急性白血病部分或者全部环节，并延长他们的生存时间。&lt;/p&gt;

&lt;h3 id=&quot;the-philadelphia-chromosome&quot;&gt;1960年，费城染色体（The Philadelphia Chromosome）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Peter Nowell and David Hungerford describe an unusually small chromosome in the cancer cells of patients with chronic myelogenous leukemia (CML). This chromosome, which becomes known as the Philadelphia chromosome, is found in the leukemia cells of 95% of patients with CML.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Peter Nowell和David Hungerford在慢性髓细胞白血病患者的癌细胞中发现了一个不常见的小段染色体。这个染色体后来被称为费城染色体，在95%的慢性髓细胞白血病患者中发现。&lt;/p&gt;

&lt;h3 id=&quot;a-focus-on-cigarette-smoking&quot;&gt;1964年，聚焦吸烟（A Focus on Cigarette Smoking）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The U.S. Surgeon General issues a report stating that cigarette smoking is an important health hazard in the United States and that action is required to reduce its harmful effects.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;美国外科总署发布报告称，在美国吸烟是重要的健康风险因素，并要求采取行动减低吸烟的有害影响。&lt;/p&gt;

&lt;h3 id=&quot;ebthe-epstein-barr-virus&quot;&gt;1964年，EB病毒（The Epstein-Barr virus）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;For the first time, a virus—the Epstein-Barr virus (EBV)—is linked to a human cancer (Burkitt lymphoma). EBV is later shown to cause several other cancers, including nasopharyngeal carcinoma, Hodgkin lymphoma, and some gastric (stomach) cancers.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;人类首次将一种病毒（EB病毒）和癌症（Burkitt淋巴癌）关联。EB病毒之后被证明会引起多种癌症，包括鼻咽癌、霍奇金淋巴瘤和一些胃癌。&lt;/p&gt;

&lt;h3 id=&quot;the-national-cancer-act&quot;&gt;1971年，全国癌症法案（The National Cancer Act）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;On December 23, President Richard M. Nixon signs the National Cancer Act, which authorizes the NCI Director to coordinate all activities of the National Cancer Program, establish national cancer research centers, and establish national cancer control programs.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;在12月23日，美国总统尼克松签署了全国癌症法案，授权NCI的院长负责协调所有国家的癌症项目，建立国家级的癌症研究中心，国家级的癌症防控项目。&lt;/p&gt;

&lt;h3 id=&quot;dnathe-dna-of-normal-chicken-cells&quot;&gt;1976年，鸡的正常细胞的DNA（The DNA of Normal Chicken Cells）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Dominique Stehelin, Harold Varmus, J. Michael Bishop, and Peter Vogt discover that the DNA of normal chicken cells contains a gene related to the oncogene (cancer-causing gene) of avian sarcoma virus, which causes cancer in chickens. This finding eventually leads to the discovery of human oncogenes.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Dominique Stehelin、Harold Varmus、J. Michael Bishop和Peter Vogt发现鸡的正常的细胞的DNA含有一个基因与禽类肉瘤病毒的癌基因相关，从而引起鸡得癌症。这个发现最终推动了对于人类癌基因的研究。&lt;/p&gt;

&lt;h3 id=&quot;tamoxifen&quot;&gt;1978年，他莫昔芬（Tamoxifen）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves tamoxifen, an antiestrogen drug originally developed as a birth control treatment, for the treatment of breast cancer. Tamoxifen represents the first of a class of drugs known as selective estrogen receptor modulators, or SERMs, to be approved for cancer therapy.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准了抗雌激素药物他莫昔芬用来治疗乳腺癌，该药原来是用来计划生育的。他莫昔芬是选择性雌激素受体调节剂这类药物中第一个被批准治疗癌症的。&lt;/p&gt;

&lt;h3 id=&quot;tp53the-tp53-gene&quot;&gt;1979年，TP53基因（The TP53 Gene）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The TP53 gene (also called p53), the most commonly mutated gene in human cancer, is discovered. It is a tumor suppressor gene, meaning its protein product (p53 protein) helps control cell proliferation and suppress tumor growth.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;TP53基因（也叫作p53）这一人类癌细胞中最常突变的基因被发现。他是一个抑癌基因，意味着其翻译的蛋白质可以控制细胞增殖、抑制癌症生长。&lt;/p&gt;

&lt;h3 id=&quot;her2her2-oncogene-identified&quot;&gt;1984年，发现HER2癌基因（HER2 Oncogene Identified）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Researchers discover a new oncogene in rat cells that they call “neu.” The human version of this gene, called HER2 (and ErbB2), is overexpressed in about 20% to 25% of breast cancers (known as HER2-positive breast cancers) and is associated with more aggressive disease and a poor prognosis.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;研究人员在大鼠的细胞中发现了一个新的癌基因，被称为“neu”。而其对应的人类基因HER2（和ErbB2）在20%-25%的乳腺癌中过表达（被称为HER2-阳性乳腺癌），并且与恶性病变、较差预后相关。&lt;/p&gt;

&lt;h3 id=&quot;hpv-16--18&quot;&gt;1984年，人乳头瘤病毒16和18（HPV 16 &amp;amp; 18）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;DNA from human papillomavirus (HPV) types 16 and 18 is identified in a large percentage of cervical cancers, establishing a link between infection with these HPV types and cervical carcinogenesis.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;人乳头瘤病毒16和18的DNA在很高比例的子宫颈癌中被发现，建立起HPV和宫颈癌变之间的关系。&lt;/p&gt;

&lt;h3 id=&quot;breast-conserving-surgery&quot;&gt;1985年，乳房保留手术（Breast-Conserving Surgery）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Results from an NCI-supported clinical trial show that women with early-stage breast cancer who were treated with breast-conserving surgery (lumpectomy) followed by whole-breast radiation therapy had similar rates of overall survival and disease-free survival as women who were treated with mastectomy alone.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;NCI资助的临床研究结果显示，早期乳腺癌妇女使用乳房保留手术联合全乳房化疗方案和乳房切除术单一方案总体生存比例和无病生存比例相似。&lt;/p&gt;

&lt;h3 id=&quot;her2her2-oncogene-cloning&quot;&gt;1986年年，HER2癌基因克隆（HER2 Oncogene Cloning）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The human oncogene HER2 (also called neu and erbB2) is cloned. Overexpression of the protein product of this gene, which occurs in about 20% to 25% of breast cancers (known as HER2-positive breast cancers), is associated with more aggressive disease and a poor prognosis.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;人类的癌基因HER2（也叫作neu和erbB2）被克隆。该基因在在20%-25%的乳腺癌中过表达（被称为HER2-阳性乳腺癌），并且与恶性病变、较差预后相关。&lt;/p&gt;

&lt;h3 id=&quot;guaiac-fecal-occult-blood-testing-fobt&quot;&gt;1993年，粪便隐血实验（Guaiac Fecal Occult Blood Testing, FOBT)&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Results from an NCI-supported clinical trial show that annual screening with guaiac fecal occult blood testing (FOBT) can reduce colorectal cancer mortality by about 33%.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;NCI资助的临床研究结果表明每年的粪便隐血试验可以降低结肠直肠癌死亡率33%。&lt;/p&gt;

&lt;h3 id=&quot;brca1brca1-tumor-suppressor-gene-cloning&quot;&gt;1994年，BRCA1抑癌基因克隆（BRCA1 Tumor Suppressor Gene Cloning）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The tumor suppressor gene BRCA1 is cloned. Specific inherited mutations in this gene greatly increase the risks of breast and ovarian cancer in women and the risks of several other cancers in both men and women.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;抑癌基因BRCA1被克隆。此基因特定的遗传性突变会极大的增加女性患乳腺癌和卵巢癌的风险，同时也会增加很多其他癌症在男性和女性中的风险。&lt;/p&gt;

&lt;h3 id=&quot;brca2brca2-tumor-suppressor-gene-cloning&quot;&gt;1995年，BRCA2抑癌基因克隆（BRCA2 Tumor Suppressor Gene Cloning）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The tumor suppressor gene BRCA2 is cloned. Similar to BRCA1, inheriting specific BRCA2 gene mutations greatly increases the risks of breast and ovarian cancer in women and the risks of several other cancers in both men and women.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;抑癌基因BRCA2被克隆。与BRCA1类似，BRCA2特定的遗传性突变会极大的增加女性患乳腺癌和卵巢癌的风险，同时也会增加很多其他癌症在男性和女性中的风险。&lt;/p&gt;

&lt;h3 id=&quot;anastrozole&quot;&gt;1996年，阿那曲唑（Anastrozole）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves anastrozole for the treatment of estrogen receptor-positive advanced breast cancer in postmenopausal women. Anastrozole is the first aromatase inhibitor (a drug that blocks the production of estrogen in the body) to be approved for cancer therapy.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准阿那曲唑治疗绝经后的雌激素受体阳性的晚期乳腺癌女性患者。阿那曲唑是第一个被批准用于治疗癌症的芳香酶抑制剂（指抑制体内雌激素产生的药物）。&lt;/p&gt;

&lt;h3 id=&quot;rituximab&quot;&gt;1997年，利妥昔单抗（Rituximab）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody, for use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL). Rituximab is later approved as an initial treatment for these types of NHL, for another type of NHL called diffuse large B-cell lymphoma, and for chronic lymphocytic leukemia.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准利妥昔单抗用于治疗耐药的、低度的或者滤泡性的B细胞非霍奇金淋巴瘤（NHL）。利妥昔单抗之后又被批准用于这些类型淋巴瘤的早期治疗，还有弥漫大B淋巴瘤和慢性粒细胞白血病。&lt;/p&gt;

&lt;h3 id=&quot;ncinci-sponsored-breast-cancer-prevention-trial&quot;&gt;1998年，NCI资助的乳腺癌预防试验（NCI-Sponsored Breast Cancer Prevention Trial）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Results of the NCI-sponsored Breast Cancer Prevention Trial show that the antiestrogen drug tamoxifen can reduce the incidence of breast cancer among women who are at increased risk of the disease by about 50%. The Food and Drug Administration (FDA) approves tamoxifen to reduce the incidence of breast cancer in women at increased risk.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;NCI资助的乳腺癌预防临床试验显示抗雌激素药物他莫昔芬可以降低乳腺癌高风险女性50%的发病率。FDA批准他莫昔芬用于降低乳腺癌高风险女性发病率。&lt;/p&gt;

&lt;h3 id=&quot;trastuzumab&quot;&gt;1998年，曲妥珠单抗（Trastuzumab）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves trastuzumab, a monoclonal antibody that targets cancer cells that overproduce the protein HER2, for the treatment of women with HER2-positive metastatic breast cancer. Trastuzumab is later approved for the adjuvant (post-operative) treatment of women with HER2-positive early-stage breast cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准曲妥珠单抗用于治疗HER2阳性的转移的乳腺癌女性患者。曲妥珠单抗后又被批准用于辅助（术后）治疗早期的HER2阳性的乳腺癌患者。&lt;/p&gt;

&lt;h3 id=&quot;imatinib-mesylate&quot;&gt;2001年，甲磺酸伊马替尼（Imatinib Mesylate）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Results of a clinical trial show that the drug imatinib mesylate, which targets a unique protein produced by the Philadelphia chromosome, is effective against chronic myelogenous leukemia (CML). Later, it is also shown to be effective in the treatment of gastrointestinal stromal tumors (GIST).&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;临床试验表明，甲磺酸伊马替尼可以作用于费城染色体产生的特异性蛋白，有效对抗慢性髓细胞白血病。之后，它又被证明可以有效治疗胃肠道间质瘤。&lt;/p&gt;

&lt;h3 id=&quot;ncinci-sponsored-prostate-cancer-prevention-trial-pcpt&quot;&gt;2003年，NCI资助的前列腺癌预防试验（NCI-Sponsored Prostate Cancer Prevention Trial, PCPT)&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Results of the NCI-sponsored Prostate Cancer Prevention Trial (PCPT) show that the drug finasteride, which reduces the production of male hormones in the body, lowers a man’s risk of prostate cancer by about 25%.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;NCI资助的前列腺癌预防试验表明降低男性体内激素的药物非那司提可以降低男性前列腺患病风险25%。&lt;/p&gt;

&lt;h3 id=&quot;ncincis-study-of-tamoxifen-and-raloxifene-star&quot;&gt;2006年，NCI的他莫昔芬和雷洛昔芬研究（NCI’s Study of Tamoxifen and Raloxifene, STAR）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Results of NCI’s Study of Tamoxifen and Raloxifene (STAR) show that postmenopausal women at increased risk of breast cancer can reduce their risk of developing the disease if they take the antiestrogen drug raloxifene. The risk of serious side effects is lower with raloxifene than with tamoxifen.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;NCI的他莫昔芬和雷洛昔芬研究显示绝经后的乳腺癌高危女性使用抗雌激素药物雷洛昔芬可以降低乳腺癌患病风险。雷洛昔芬比他莫昔芬引起严重副作用的风险要小。&lt;/p&gt;

&lt;h3 id=&quot;gardasil&quot;&gt;2006年，加卫苗（Gardasil）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves the human papilloma virus (HPV) vaccine Gardasil, which protects against infection by the two types of HPV that cause approximately 70% of all cases of cervical cancer. NCI scientists developed the underlying technology used to make Gardasil.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准人乳头瘤病毒疫苗加卫苗，它可以防止两种HPV病毒感染，这两种病毒引起了70%的子宫颈癌。NCI的科学家研发了用于生产加卫苗的基础技术。&lt;/p&gt;

&lt;h3 id=&quot;cervarix&quot;&gt;2009年，卉妍康（Cervarix）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves Cervarix, a second vaccine that protects against infection by the two types of the human papilloma virus (HPV) that cause approximately 70% of all cases of cervical cancer worldwide. NCI scientists developed the underlying technology used to make Cervarix.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准卉妍康，第二个防止两种HPV病毒感染的疫苗。NCI的科学家研发了用于生产加卫苗的基础技术。&lt;/p&gt;

&lt;h3 id=&quot;the-first-human-cancer-treatment-vaccine&quot;&gt;2010年，首个人类癌症治疗疫苗（The First Human Cancer Treatment Vaccine）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves sipuleucel-T, a cancer treatment vaccine that is made using a patient’s own immune system cells (dendritic cells), for the treatment of metastatic prostate cancer that no longer responds to hormonal therapy. It is the first (and so far only) human cancer treatment vaccine to be approved.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准了癌症治疗疫苗sipuleucel-T，它可以利用病人自身的免疫系统细胞（树状突细胞）治疗转移的、激素疗法不响应的前列腺癌。它也是第一个（迄今为止唯一一个）被批准的人类癌症治疗疫苗。&lt;/p&gt;

&lt;h3 id=&quot;ncinci-sponsored-lung-cancer-screening-tiral-nlst&quot;&gt;2010年，NCI资助的肺癌筛查试验（NCI-Sponsored Lung Cancer Screening Tiral, NLST)&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Initial results of the NCI-sponsored Lung Cancer Screening Trial (NLST) show that screening with low-dose helical computerized tomography (CT) reduced lung cancer deaths by about 20% in a large group of current and former heavy smokers.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;NCI资助的肺癌筛查试验表明，使用小剂量螺旋CT筛查可以降低现在和之前的重度吸烟者20%的肺癌死亡率。&lt;/p&gt;

&lt;h3 id=&quot;ipilimumab&quot;&gt;2011年，易普利姆玛（Ipilimumab）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The Food and Drug Administration (FDA) approves the use of ipilimumab, a monoclonal antibody, for the treatment of inoperable or metastatic melanoma. Ipilimumab stimulates the immune system to attack cancer cells by removing a “brake” that normally controls the intensity of immune responses.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准单克隆抗体易普利姆玛用于治疗手术不能治或者转移的黑色素瘤。易普利姆玛可以移除正常状态下控制免疫反应强度的“刹车”，刺激免疫系统去攻击癌细胞。&lt;/p&gt;

&lt;h3 id=&quot;ncinci-sponsored-plco-cancer-screening-trial&quot;&gt;2012年，NCI资助的前列腺、肺、结肠和卵巢癌筛查试验（NCI-Sponsored PLCO Cancer Screening Trial）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Results of the NCI-sponsored PLCO Cancer Screening Trial confirm that screening people 55 years of age and older for colorectal cancer using flexible sigmoidoscopy reduces colorectal cancer incidence and mortality. In the PLCO, screened individuals had a 21% lower risk of developing colorectal cancer and a 26% lower risk of dying from the disease than the control subjects.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;NCI资助的前列腺、肺、结肠和卵巢癌筛查试验证实55岁以上人群可屈性乙状结肠镜检查可以降低结肠直肠癌的发病率和死亡率。在这次试验中，与对照组相比，筛查患者结直肠癌风险降低21%，因此死亡的风险降低26%。&lt;/p&gt;

&lt;h3 id=&quot;ado-trastuzumab-emtansine-t-dm1&quot;&gt;2013年，曲妥珠单抗共轭复合物（Ado-Trastuzumab Emtansine, T-DM1)&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The FDA approves ado-trastuzumab emtansine (T-DM1) for the treatment of patients with HER2-positive breast cancer who were previously treated with trastuzumab and/or a taxane drug. T-DM1 is an immunotoxin (an antibody-drug conjugate) that is made by chemically linking the monoclonal antibody trastuzumab to the cytotoxic agent mertansine, which inhibits cell proliferation by blocking the formation of microtubules.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准曲诺珠单抗共轭复合物（T-DM1）用于治疗曲诺珠单抗或者紫杉醇耐药的HER2阳性的乳腺癌患者。T-DM1是一个免疫毒素（抗体-药物共轭），化学上通过连接曲诺珠单抗和细胞毒性药物mertansine生成，可以通过阻断微管形成抑制细胞增殖。&lt;/p&gt;

&lt;h3 id=&quot;dnaanalyzing-dna-in-cancer&quot;&gt;2014年，癌症的DNA分析（Analyzing DNA in Cancer）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Researchers from The Cancer Genome Atlas (TCGA) project, a joint effort by NCI and the National Human Genome Research Institute to analyze the DNA and other molecular changes in more than 30 types of human cancer, find that gastric (stomach) cancer is actually four different diseases, not just one, based on differing tumor characteristics. This finding from TCGA and other related projects may potentially lead to a new classification system for cancer, in which cancers are classified by their molecular abnormalities as well as their organ or tissue site of origin.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;来自于一项由NCI和NHGRI联合资助的癌症与肿瘤图谱计划（TCGA）的研究者通过分析超过30种人类癌症的DNA和其他分子改变发现，胃癌基于癌症特征，其实是4中不同疾病，而不是一种。TCGA和其他计划的研究很有可能推动新的癌症分型系统，即使用分子异常结合组织、器官原发部位进行分类。&lt;/p&gt;

&lt;h3 id=&quot;pembrolizumab&quot;&gt;2014年，Pembrolizumab&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;The FDA approves pembrolizumab for the treatment of advanced melanoma. This monoclonal antibody blocks the activity of a protein called PD1 on immune cells, which increases the strength of immune responses against cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;FDA批准pembrolizumab用于治疗晚期黑色素瘤。此单克隆抗体可以阻断免疫细胞中PD1蛋白的活性，增强免疫系统对癌症的反应性。&lt;/p&gt;
</description>
        <pubDate>Mon, 21 Nov 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/11/21/cancer-milestone.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/11/21/cancer-milestone.html</guid>
        
        <category>medi</category>
        
        <category>bio</category>
        
        
      </item>
    
      <item>
        <title>口腔鳞状细胞癌资料翻译之默克手册</title>
        <description>&lt;p&gt;注：文本翻译自Merck Manual的&lt;a href=&quot;http://www.merckmanuals.com/professional/ear,-nose,-and-throat-disorders/tumors-of-the-head-and-neck/oral-squamous-cell-carcinoma&quot;&gt;《Oral squamous cell carcinoma》&lt;/a&gt;。&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;Oral squamous cell carcinoma affects about 30,000 people in the US each year. Over 95% smoke tobacco, drink alcohol, or both. Early, curable lesions are rarely symptomatic; thus, preventing fatal disease requires early detection by screening. Treatment is with surgery, radiation, or both, although surgery plays a larger role in the treatment of most oral cavity cancer. The overall 5-yr survival rate (all sites and stages combined) is &amp;gt; 50%.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;在美国，每年有约3万人得口腔的鳞状细胞癌。超过95%的患者抽烟、或喝酒、或又抽烟又喝酒的。早期的可治愈阶段的病变很少有症状，因此，要早期检测、早期筛查才能预防致命的病变。治疗方法可以是手术、放疗、或者结合，尽管手术所占的比例更大。总体的5年生存率（所有的位置、所有的阶段都算上）是大于50%的。&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;Oral cancer refers to cancer occurring between the vermilion border of the lips and the junction of the hard and soft palates or the posterior one third of the tongue.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;In the US, 3% of cancers in men and 2% in women are oral squamous cell carcinomas, most of which occur after age 50. As with most head and neck sites, squamous cell carcinoma is the most common oral cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;The chief risk factors for oral squamous cell carcinoma are&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Smoking (especially &amp;gt; 2 packs/day)&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Alcohol use&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;p&gt;口腔癌症指的是发生在嘴唇红色边缘、硬腭与软腭链接处、或者舌头后三分之一之间的癌症。&lt;/p&gt;

&lt;p&gt;在美国，3%的男性癌症、2%的女性癌症是口腔鳞状细胞癌，大多数发生在50岁之后。和大多头部和颈部一样，鳞状细胞癌是最常见的口腔癌症。&lt;/p&gt;

&lt;p&gt;鳞状细胞癌的主要的危险因素是：&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;吸烟（尤其是每天大于2包）&lt;/li&gt;
  &lt;li&gt;饮酒&lt;/li&gt;
&lt;/ul&gt;

&lt;blockquote&gt;
  &lt;p&gt;Risk increases dramatically when alcohol use exceeds 6 oz of distilled liquor, 15 oz of wine, or 36 oz of beer/day. The combination of heavy smoking and alcohol abuse is estimated to raise the risk 100-fold in women and 38-fold in men.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Squamous cell carcinoma of the tongue may also result from any chronic irritation, such as dental caries, overuse of mouthwash, chewing tobacco, or the use of betel quid. Oral human papillomavirus (HPV), typically acquired via oral-genital contact, may have a role in the etiology of some oral cancers; however, the role of HPV is not as clearly defined in oral cancer as it is in oropharyngeal cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;About 40% of intraoral squamous cell carcinomas begin on the floor of the mouth or on the lateral and ventral surfaces of the tongue. About 38% of all oral squamous cell carcinomas occur on the lower lip; these are usually solar-related cancers on the external surface.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;当饮酒超过每天6盎司的蒸馏酒、15盎司的葡萄酒、或者36盎司的啤酒时，风险会显著提高。同时重度吸烟和酒精滥用被估计会提高女性100倍的患病风险，男性38倍的患病风险。&lt;/p&gt;

&lt;p&gt;舌头的鳞状细胞癌也可能由于一些慢性的刺激，如龋齿，漱口水使用过度、咀嚼烟草、使用槟榔。口腔人乳头瘤病毒（HPV）也被认为是一些口腔癌症的病因，然而，相比于咽喉的癌症，HPV对口腔癌症的作用并不是特别清晰。&lt;/p&gt;

&lt;p&gt;大约40%的口腔内鳞状细胞癌从口腔底部或者舌头表面开始，大约38%的口腔鳞状细胞癌发生在下唇，这些在外表面的经常是与太阳有关的癌症。&lt;/p&gt;

&lt;h2 id=&quot;symptoms-and-signs&quot;&gt;症状（Symptoms and Signs）&lt;/h2&gt;
&lt;blockquote&gt;
  &lt;p&gt;Oral lesions are asymptomatic initially, highlighting the need for oral screening. Most dental professionals carefully examine the oral cavity and oropharynx during routine care and may do a brush biopsy of abnormal areas. The lesions may appear as areas of erythroplakia or leukoplakia and may be exophytic or ulcerated. Cancers are often indurated and firm with a rolled border. As the lesions increase in size, pain, dysarthria, and dysphagia may result.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;口腔病变最开始经常是无症状的，这也能突显口腔检查的重要性。大多数的专业牙医在常规体检时会小心检查口腔和咽喉部位，也许会在异常部位用刷子取一些组织。当区域出现红斑或白斑、当出现外生活着溃疡，病症也许会显现。癌症经常是坚硬的、有点滚边的。随着病症逐渐扩大，疼痛、情绪失控和吞咽困难也许会发生。&lt;/p&gt;

&lt;h2 id=&quot;diagnosis&quot;&gt;Diagnosis&lt;/h2&gt;
&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Biopsy&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Endoscopy to detect second primary cancer&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Chest x-ray and CT of head and neck&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Any suspicious areas should be biopsied. Incisional or brush biopsy can be done depending on the surgeon’s preference. Direct laryngoscopy and esophagoscopy are done in all patients with oral cavity cancer to exclude a simultaneous second primary cancer. Head and neck CT usually is done and a chest x-ray is done; however, as in most sites in the head and neck, PET/CT has begun to play a larger role in the evaluation of patients with oral cavity cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;h2 id=&quot;prognosis&quot;&gt;预后（Prognosis）&lt;/h2&gt;
&lt;blockquote&gt;
  &lt;p&gt;If carcinoma of the tongue is localized (no lymph node involvement), 5-yr survival is &amp;gt; 75%. For localized carcinoma of the floor of the mouth, 5-yr survival is 75%. Lymph node metastasis decreases survival rate by about half. Metastases reach the regional lymph nodes first and later the lungs.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;For lower lip lesions, 5-yr survival is 90%, and metastases are rare. Carcinoma of the upper lip tends to be more aggressive and metastatic.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;h2 id=&quot;treatment&quot;&gt;治疗（Treatment）&lt;/h2&gt;
&lt;blockquote&gt;
  &lt;p&gt;Surgery, with postoperative radiation or chemoradiation as needed&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;For most oral cavity cancers, surgery is the initial treatment of choice. Radiation or chemoradiation is added postoperatively if disease is more advanced or has high-risk features. (See also the National Cancer Institute’s summary Lip and Oral Cavity Cancer Treatment .)&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Selective neck dissection is indicated if the risk of nodal disease exceeds 15 to 20%. Although there is no firm consensus, neck dissections are typically done for T2 (see Table: Staging of Head and Neck Cancer) lesions (greatest dimension 2 to 4 cm) and most T1 lesions with a depth of invasion about ≥ 4 mm.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Routine surgical reconstruction is the key to reducing postoperative oral disabilities; procedures range from local tissue flaps to free tissue transfers. Speech and swallowing therapy may be required after significant resections.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Radiation therapy is an alternative treatment. Chemotherapy is not used routinely as primary therapy but is recommended as adjuvant therapy along with radiation in patients with advanced nodal disease.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Treatment of squamous cell carcinoma of the lip is surgical excision with reconstruction to maximize postoperative function. When large areas of the lip exhibit premalignant change, the lip can be surgically shaved, or a laser can remove all affected mucosa. Mohs surgery can be used. Thereafter, appropriate sunscreen application is recommended.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;h2 id=&quot;key-points&quot;&gt;Key Points&lt;/h2&gt;
&lt;blockquote&gt;
  &lt;p&gt;The chief risk factors for oral squamous cell carcinoma are heavy smoking and alcohol use.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Oral cancer is sometimes asymptomatic initially, so oral screening (typically by dental professionals) is useful for early diagnosis.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Do direct laryngoscopy and esophagoscopy to exclude a simultaneous second primary cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Once cancer is confirmed, do head and neck CT and a chest x-ray or PET/CT.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Initial treatment is usually surgical.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;h2 id=&quot;more-information&quot;&gt;更多信息（More Information）&lt;/h2&gt;

&lt;p&gt;美国国立癌症研究院的总结（National Cancer Institute’s Summary） &lt;a href=&quot;http://www.cancer.gov/cancertopics/pdq/treatment/lip-and-oral-cavity/HealthProfessional&quot;&gt;《Lip and Oral Cavity Cancer Treatment》&lt;/a&gt;&lt;/p&gt;

&lt;h2 id=&quot;section&quot;&gt;链接&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;&lt;a href=&quot;http://www.merckmanuals.com/professional/ear,-nose,-and-throat-disorders/tumors-of-the-head-and-neck/oral-squamous-cell-carcinoma&quot;&gt;Oral Squamous Cell Carcinoma&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
</description>
        <pubDate>Sun, 20 Nov 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/11/20/oralSCC-merck.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/11/20/oralSCC-merck.html</guid>
        
        <category>medi</category>
        
        <category>bio</category>
        
        
      </item>
    
      <item>
        <title>鳞状细胞癌资料翻译之梅奥诊所</title>
        <description>&lt;h2 id=&quot;overview&quot;&gt;Overview(概述)&lt;/h2&gt;

&lt;blockquote&gt;
  &lt;p&gt;Squamous cell carcinoma of the skin is a common form of skin cancer that develops in the squamous cells that make up the middle and outer layer of the skin.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Squamous cell carcinoma of the skin is usually not life-threatening, though it can be aggressive in some cases. Untreated, squamous cell carcinoma of the skin can grow large or spread to other parts of your body, causing serious complications.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Most squamous cell carcinomas of the skin result from prolonged exposure to ultraviolet (UV) radiation, either from sunlight or from tanning beds or lamps. Avoiding UV light helps reduce your risk of squamous cell carcinoma of the skin and other forms of skin cancer.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Squamous cells are found in many places in your body and squamous cell carcinoma can occur anywhere squamous cells are found. Squamous cell carcinoma of the skin refers to cancer that forms in the squamous cells found in the skin.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;鳞状细胞癌（Squamous cell carcinoma, SCC）是皮肤癌的一种常见形式，主要发生在中层和外层皮肤的鳞状细胞中。&lt;/p&gt;

&lt;p&gt;鳞状细胞癌经常不会危及生命，尽管某些情况会比较恶性。不治疗的鳞状皮肤癌会变大或者蔓延至身体的其他部位，引起严重的并发症。&lt;/p&gt;

&lt;p&gt;大多数的鳞状细胞癌是由于过度的紫外线（UV）暴露导致的，或者是来自于阳光，或者是来自于晒黑床和灯。避免紫外线会有助于降低患鳞状细胞癌和其他皮肤癌的风险。&lt;/p&gt;

&lt;p&gt;鳞状细胞存在于身体的很多部分，而鳞状细胞癌也可以在身体的很多地方发现。鳞状细胞指的就是在皮肤的鳞状细胞中发现的癌症。&lt;/p&gt;

&lt;h2 id=&quot;symptoms-and-causes&quot;&gt;Symptoms and causes（症状和病因）&lt;/h2&gt;

&lt;h3 id=&quot;symptoms&quot;&gt;Symptoms（症状）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Squamous cell carcinoma of the skin most often occurs on sun-exposed skin, such as your scalp, the backs of your hands, your ears or your lips. But squamous cell carcinoma of the skin can occur anywhere on your body, including inside your mouth, on your anus and on your genitals.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;Signs and symptoms of squamous cell carcinoma of the skin include:&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;A firm, red nodule
A flat sore with a scaly crust
A new sore or raised area on an old scar or ulcer
A rough, scaly patch on your lip that may evolve to an open sore
A red sore or rough patch inside your mouth
A red, raised patch or wart-like sore on or in the anus or on your genitals&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;鳞状细胞癌经常发生在曝露在太阳光下的皮肤上，例如头皮、手背、耳朵或者是嘴唇。但是鳞状细胞癌也可以发生在其他部位，包括嘴、肛门或者是生殖器等。&lt;/p&gt;

&lt;p&gt;鳞状细胞癌的症状包括：&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;一个坚硬、红色的节洁&lt;/li&gt;
  &lt;li&gt;扁平的疮，鳞片状的皮&lt;/li&gt;
  &lt;li&gt;一个新的疮、或者是旧疮、溃疡&lt;/li&gt;
  &lt;li&gt;一个粗的、鳞片状的半点在嘴唇，也许会恶化成一个疮&lt;/li&gt;
  &lt;li&gt;一个红的疮、或者粗的斑点在嘴里&lt;/li&gt;
  &lt;li&gt;一个红的、升起的斑点、肉赘样的疮在肛门或者生殖器上&lt;/li&gt;
&lt;/ul&gt;

&lt;h4 id=&quot;when-to-see-a-doctor&quot;&gt;When to see a doctor（什么时候去看医生）&lt;/h4&gt;

&lt;blockquote&gt;
  &lt;p&gt;Make an appointment with your doctor if you have a sore or scab that doesn’t heal in about two months or a flat patch of scaly skin that won’t go away.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;如果疮或者痂两个月内无法痊愈，或者是一个平的、鳞片状的斑点无法去除，可以预约你的医生。&lt;/p&gt;

&lt;h3 id=&quot;causes&quot;&gt;causes（病因）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Squamous cell carcinoma of the skin occurs when the flat, thin squamous cells in the outer layer of your skin develop errors in their DNA. Ordinarily, new cells push older cells toward your skin’s surface, and the older cells die and are sloughed off. DNA errors disrupt this orderly pattern, causing cells to grow out of control, with squamous cell carcinoma of the skin as the result.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;当你外层皮肤中平的、薄的鳞状细胞的DNA发生错误的时候，你可能会得鳞状细胞癌。通常下，你的新细胞会将老细胞推到皮肤表面，老细胞会死掉后脱落。DNA的错误会干扰这种正常的模式，使得细胞增长失去控制，导致鳞状细胞癌。&lt;/p&gt;

&lt;h4 id=&quot;ultraviolet-light-and-other-potential-causes&quot;&gt;Ultraviolet light and other potential causes（紫外线或其他潜在危险）&lt;/h4&gt;

&lt;blockquote&gt;
  &lt;p&gt;Much of the damage to DNA in skin cells results from ultraviolet (UV) radiation found in sunlight and in commercial tanning lamps and tanning beds.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;But sun exposure doesn’t explain skin cancers that develop on skin not ordinarily exposed to sunlight. This indicates that other factors may contribute to your risk of skin cancer, such as being exposed to toxic substances or having a condition that weakens your immune system.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;很多的皮肤细胞的DNA损伤是由阳光和商业的晒黑灯、晒黑床的紫外线辐射导致的。&lt;/p&gt;

&lt;p&gt;但是太阳照射无法解释那些不暴露在阳光下部位得到的鳞状皮肤癌。这说明还有其他因素会导致皮肤癌危险的增高，例如暴露在有毒物质下，或者是某种情况下你的免疫能力下降。&lt;/p&gt;

&lt;h3 id=&quot;risk-factors&quot;&gt;Risk factors（危险因素）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Factors that may increase your risk of squamous cell carcinoma of the skin include:&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Fair skin. Anyone, regardless of skin color, can get squamous cell carcinoma of the skin. However, having less pigment (melanin) in your skin provides less protection from damaging UV radiation.&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;If you have blond or red hair and light-colored eyes and you freckle or sunburn easily, you’re much more likely to develop skin cancer than is a person with darker skin.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Excessive sun exposure. Being exposed to UV light from the sun increases your risk of squamous cell carcinoma of the skin. Spending lots of time in the sun — particularly if you don’t cover your skin with clothing or sunblock — increases your risk of squamous cell carcinoma of the skin even more.&lt;/li&gt;
    &lt;li&gt;Use of tanning beds. People who use indoor tanning beds have an increased risk of squamous cell carcinoma of the skin.&lt;/li&gt;
    &lt;li&gt;A history of sunburns. Having had one or more blistering sunburns as a child or teenager increases your risk of developing squamous cell carcinoma of the skin as an adult. Sunburns in adulthood also are a risk factor.&lt;/li&gt;
    &lt;li&gt;A personal history of precancerous skin lesions. Having a precancerous skin lesion, such as actinic keratosis or Bowen’s disease, increases your risk of squamous cell carcinoma of the skin.
A personal history of skin cancer. If you’ve had squamous cell carcinoma of the skin once, you’re much more likely to develop it again.&lt;/li&gt;
    &lt;li&gt;Weakened immune system. People with weakened immune systems have an increased risk of skin cancer. This includes people who have leukemia or lymphoma and those who take medications that suppress the immune system, such as those who have undergone organ transplants.&lt;/li&gt;
    &lt;li&gt;Rare genetic disorder. People with xeroderma pigmentosum, which causes an extreme sensitivity to sunlight, have a greatly increased risk of developing skin cancer.&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;p&gt;也许会增高得鳞状皮肤癌的危险因素包括：&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;白皮肤：&lt;/li&gt;
&lt;/ul&gt;

&lt;h3 id=&quot;complications&quot;&gt;Complications（并发症）&lt;/h3&gt;

&lt;blockquote&gt;
  &lt;p&gt;Untreated squamous cell carcinoma of the skin can destroy nearby healthy tissue, spread to the lymph nodes or other organs, and may be fatal, although this is uncommon.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;p&gt;The risk of aggressive squamous cell carcinoma of the skin may be increased in cases where the cancer:&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Is particularly large or deep&lt;/li&gt;
    &lt;li&gt;Involves the mucous membranes, such as the lips&lt;/li&gt;
    &lt;li&gt;Occurs in a person with a weakened immune system, such as someone who takes anti-rejection medications after an organ transplant or someone who has chronic leukemia&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;h2 id=&quot;diagnosis&quot;&gt;Diagnosis（诊断）&lt;/h2&gt;

&lt;blockquote&gt;
  &lt;p&gt;Tests and procedures used to diagnose squamous cell carcinoma of the skin include:&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Physical exam. Your doctor will ask questions about your health history and examine your skin to look for signs of squamous cell carcinoma of the skin.&lt;/li&gt;
    &lt;li&gt;Removing a sample of tissue for testing. To confirm a squamous cell carcinoma of the skin diagnosis, your doctor will use a tool to cut away some or all of the suspicious skin lesion (biopsy). What type of skin biopsy you undergo depends on your particular situation. The tissue is sent to a laboratory for examination.&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;p&gt;用于诊断鳞状细胞癌的检测和过程包括：&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;物理检查：你的医生会问你健康史、检查你的皮肤、看你皮肤鳞状细胞癌的症状。&lt;/li&gt;
  &lt;li&gt;取组织样本检测：为了确认你的鳞状细胞癌，你的医生会使用工具切除部分或者全部的疑似病变皮肤。取哪种皮肤组织样本取决于具体的情况。样本会送到实验室进行检查。&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;treatment&quot;&gt;Treatment（治疗）&lt;/h2&gt;

&lt;blockquote&gt;
  &lt;p&gt;Most squamous cell carcinomas of the skin can be completely removed with relatively minor surgery or occasionally with a topical medication. Which squamous cell carcinoma of the skin treatments are best for you depends on the size, location and aggressiveness of the tumor, as well as your own preferences.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;大部分的鳞状细胞癌可以通过较小的手术或者有时通过局部给药完全去除。至于选择哪种治疗方法，取决于癌症的大小、位置和恶性情况，还有你自己的个人选择。&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;Treatments may include:&lt;/p&gt;
&lt;/blockquote&gt;

&lt;blockquote&gt;
  &lt;ul&gt;
    &lt;li&gt;Electrodesiccation and curettage (ED and C). ED and C treatment involves removing the surface of the skin cancer with a scraping instrument (curet) and then searing the base of the cancer with an electric needle. This treatment is often used for very small squamous cell cancers of the skin.&lt;/li&gt;
    &lt;li&gt;Curettage and cryotherapy. Similar to the ED and C procedure, after the tumor removal and curettage, the base and edges of the biopsy site are treated with liquid nitrogen.&lt;/li&gt;
    &lt;li&gt;Laser therapy. An intense beam of light vaporizes growths, usually with little damage to surrounding tissue and with a reduced risk of bleeding, swelling and scarring. Laser treatment may be an option for very superficial skin lesions.&lt;/li&gt;
    &lt;li&gt;Freezing. This treatment involves freezing cancer cells with liquid nitrogen (cryosurgery). It may be an option for treating superficial skin lesions.&lt;/li&gt;
    &lt;li&gt;Photodynamic therapy. Photodynamic therapy combines photosensitizing drugs and light to treat superficial skin cancers. During photodynamic therapy, a liquid drug that makes the cancer cells sensitive to light is applied to the skin. Later, a light that destroys the skin cancer cells is shined on the area.&lt;/li&gt;
    &lt;li&gt;Medicated creams or lotions. For very superficial cancers, you may apply creams or lotions containing anti-cancer medications directly to your skin.&lt;/li&gt;
    &lt;li&gt;Simple excision. In this procedure, your doctor cuts out the cancerous tissue and a surrounding margin of healthy skin. Your doctor may recommend removing additional normal skin around the tumor in some cases (wide excision). To minimize scarring, especially on your face, consult a doctor skilled in skin reconstruction.&lt;/li&gt;
    &lt;li&gt;Mohs surgery. During Mohs surgery, your doctor removes the cancer layer by layer, examining each layer under the microscope until no abnormal cells remain. This allows the surgeon to be certain the entire growth is removed and avoid taking an excessive amount of surrounding healthy skin.&lt;/li&gt;
    &lt;li&gt;Radiation therapy. Radiation therapy uses high-energy beams, such as X-rays, to kill cancer cells. This may be an option for treating deeper tumors, those that have a risk of returning after surgery and tumors in people who can’t undergo surgery.&lt;/li&gt;
  &lt;/ul&gt;
&lt;/blockquote&gt;

&lt;p&gt;治疗包括：&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;电干燥法和刮除术（ED&amp;amp;C）：ED&amp;amp;C方法涉及使用刮刀去除癌症表面皮肤，然后用电针去灼烧癌症的组织。这种方法常用于比较小的鳞状细胞癌。&lt;/li&gt;
  &lt;li&gt;刮除术和低温疗法（Curettage and cryotherapy）：与ED&amp;amp;C疗法步骤类似，在去除癌症组织后，组织部位和边缘使用液氮处理。&lt;/li&gt;
  &lt;li&gt;激光疗法（Laser therapy）：一束强光使扩增部位蒸发。此种方法通常对于周边组织的损害较小，并且降低流血、肿胀、结疤的风险。激光疗法也许是比较浅的皮肤癌的一种选择。&lt;/li&gt;
  &lt;li&gt;冷冻（Freezing）：这种方法涉及使用液氮去冷冻癌细胞。这也许也是比较浅的皮肤癌的一种选择。&lt;/li&gt;
  &lt;li&gt;光动力疗法（Photodynamic therapy）：这种方法结合药物和光去处理浅的皮肤癌。在治疗过程中，一个液体药物会涂在皮肤上，使其对光更敏感。之后，可以消灭皮肤癌细胞的光作用在此区域。&lt;/li&gt;
  &lt;li&gt;药用乳膏（Medicated creams or lotions）：对于比较浅的癌症，你可以直接涂含有抗癌药物的乳膏在皮肤上。&lt;/li&gt;
  &lt;li&gt;简单切除（Simple excision）&lt;/li&gt;
  &lt;li&gt;Mohs手术（Mohs Surgery）&lt;/li&gt;
  &lt;li&gt;放疗（Radiation therapy）&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;section&quot;&gt;链接&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;&lt;a href=&quot;http://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/home/ovc-20204362&quot;&gt;Squamous cell carcinoma of the skin&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
</description>
        <pubDate>Fri, 18 Nov 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/11/18/SCC-mayoclinic.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/11/18/SCC-mayoclinic.html</guid>
        
        <category>medi</category>
        
        <category>bio</category>
        
        
      </item>
    
      <item>
        <title>基因组分析的benchmark数据</title>
        <description>&lt;h2 id=&quot;section&quot;&gt;两篇文献&lt;/h2&gt;

&lt;ol&gt;
  &lt;li&gt;Zook, J. M., Chapman, B., Wang, J., Mittelman, D., Hofmann, O., Hide, W., &amp;amp; Salit, M. (2014). Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls. Nature Biotechnology, 32(3), 246–251. &lt;a href=&quot;http://doi.org/10.1038/nbt.2835&quot;&gt;http://doi.org/10.1038/nbt.2835&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;Zook, J. M., Catoe, D., McDaniel, J., Vang, L., Spies, N., Sidow, A., … Salit, M. (2016). Extensive sequencing of seven human genomes to characterize benchmark reference materials. Scientific Data, 3, 160025. &lt;a href=&quot;http://doi.org/10.1038/sdata.2016.25&quot;&gt;http://doi.org/10.1038/sdata.2016.25&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;

&lt;h2 id=&quot;section-1&quot;&gt;相关组织&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;http://jimb.stanford.edu/giab/&quot;&gt;GIAB(Genome in a Bottle)&lt;/a&gt;: a public-private-academic consortium hosted by NIST to develop the technical infrastructure (reference standards, reference methods, and reference data) to enable translation of whole human genome sequencing to clinical practice.&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://www.nist.gov/&quot;&gt;NIST(National Institute of Standards and Technology)&lt;/a&gt;: founded in 1901 and now part of the U.S. Department of Commerce, one of the nation’s oldest physical science laboratories.&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://catalog.coriell.org/&quot;&gt;Coriell Institute for Medical Research&lt;/a&gt;: Providing essential research specimens and custom services to the scientific community, Coriell Biorepositories and Services is the international resource for exceptional science.&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://catalog.coriell.org/1/NIGMS/Collections/CEPH-Resources&quot;&gt;CEPH Resources(The Centre de’Etude du Polymorphism Humain)&lt;/a&gt;:  has contributed its collection of 61 reference families to the Repository.&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://catalog.coriell.org/1/NIGMS/Collections/NIST-Reference-Materials&quot;&gt;NIST Reference Material&lt;/a&gt;: The Genome in a Bottle Consortium has selected several genomes to produce and characterize as reference materials. The National Institute of Standards and Technology (NIST) has developed NIST Reference Materials from these genomes, which are DNA extracted from a large homogenized growth of B lymphoblastoid cell lines from the NIGMS Human Genetic Cell Repository at Coriell Institute for Medical Research.&lt;/p&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;section-2&quot;&gt;相关样本&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://catalog.coriell.org/0/Sections/Search/Sample_Detail.aspx?Ref=NA12878&amp;amp;Product=DNA&quot;&gt;NA12878&lt;/a&gt;: In 2015, NIST released the pilot genome Reference Material 8398, which is genomic DNA (NA12878) derived from a large batch of the Coriell cell line GM12878, characterized for high-confidence SNPs, indel, and homozygous reference regions (Zook, et al., Nature Biotechnology 2014).&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://www.nist.gov/news-events/news/2016/09/nist-releases-new-family-standardized-genomes&quot;&gt;four new GIAB reference materials&lt;/a&gt;: With the addition of four new reference materials (RMs) to a growing collection of “measuring sticks” for gene sequencing, the National Institute of Standards and Technology (NIST) can now provide laboratories with even more capability to accurately “map” DNA for genetic testing, medical diagnoses and future customized drug therapies&lt;/p&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;img src=&quot;/images/benchmark-reference-material.png&quot; alt=&quot;&quot; /&gt;&lt;/p&gt;

&lt;h2 id=&quot;section-3&quot;&gt;相关技术&lt;/h2&gt;

&lt;p&gt;&lt;img src=&quot;/images/benchmark-12-technologies.png&quot; alt=&quot;&quot; /&gt;&lt;/p&gt;

&lt;h2 id=&quot;section-4&quot;&gt;下载链接&lt;/h2&gt;

&lt;p&gt;&lt;a href=&quot;https://github.com/genome-in-a-bottle/giab_data_indexes&quot;&gt;https://github.com/genome-in-a-bottle/giab_data_indexes&lt;/a&gt;&lt;/p&gt;
</description>
        <pubDate>Sat, 22 Oct 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/10/22/DNA-seq_reference_data.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/10/22/DNA-seq_reference_data.html</guid>
        
        <category>bioinfo</category>
        
        
      </item>
    
      <item>
        <title>吉他学习</title>
        <description>&lt;ul id=&quot;markdown-toc&quot;&gt;
  &lt;li&gt;&lt;a href=&quot;#section&quot; id=&quot;markdown-toc-section&quot;&gt;吉他的种类&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;#practice-tips&quot; id=&quot;markdown-toc-practice-tips&quot;&gt;practice tips&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;#section-1&quot; id=&quot;markdown-toc-section-1&quot;&gt;乐理知识&lt;/a&gt;    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;#section-2&quot; id=&quot;markdown-toc-section-2&quot;&gt;音符时值&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#section-3&quot; id=&quot;markdown-toc-section-3&quot;&gt;音&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#section-4&quot; id=&quot;markdown-toc-section-4&quot;&gt;音阶&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#section-5&quot; id=&quot;markdown-toc-section-5&quot;&gt;拍号&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#section-6&quot; id=&quot;markdown-toc-section-6&quot;&gt;吉他空弦&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#mi&quot; id=&quot;markdown-toc-mi&quot;&gt;mi指型&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#section-7&quot; id=&quot;markdown-toc-section-7&quot;&gt;音程&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#section-8&quot; id=&quot;markdown-toc-section-8&quot;&gt;和弦&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;#section-9&quot; id=&quot;markdown-toc-section-9&quot;&gt;有用的链接&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;&lt;a href=&quot;#section-10&quot; id=&quot;markdown-toc-section-10&quot;&gt;常见和弦&lt;/a&gt;    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;#em&quot; id=&quot;markdown-toc-em&quot;&gt;Em&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#am&quot; id=&quot;markdown-toc-am&quot;&gt;Am&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#c&quot; id=&quot;markdown-toc-c&quot;&gt;C&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#dm&quot; id=&quot;markdown-toc-dm&quot;&gt;Dm&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#g&quot; id=&quot;markdown-toc-g&quot;&gt;G&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#fmaj7&quot; id=&quot;markdown-toc-fmaj7&quot;&gt;Fmaj7&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#d&quot; id=&quot;markdown-toc-d&quot;&gt;D&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#am7&quot; id=&quot;markdown-toc-am7&quot;&gt;Am7&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;#bm&quot; id=&quot;markdown-toc-bm&quot;&gt;Bm&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;section&quot;&gt;吉他的种类&lt;/h2&gt;

&lt;ol&gt;
  &lt;li&gt;Electric：电子吉他&lt;/li&gt;
  &lt;li&gt;Acoustic：木吉他&lt;/li&gt;
  &lt;li&gt;Classical：古典吉他&lt;/li&gt;
&lt;/ol&gt;

&lt;h2 id=&quot;practice-tips&quot;&gt;practice tips&lt;/h2&gt;

&lt;p&gt;source: &lt;a href=&quot;http://www.justinguitar.com/en/BC-105-PracticeTips.php&quot;&gt;http://www.justinguitar.com/en/BC-105-PracticeTips.php&lt;/a&gt;&lt;/p&gt;

&lt;ol&gt;
  &lt;li&gt;Practice what you can’t do, not what you can.&lt;/li&gt;
  &lt;li&gt;Never practice making a mistake. Get it right.&lt;/li&gt;
  &lt;li&gt;Start slowly and get it right before you speed up.&lt;/li&gt;
  &lt;li&gt;Using a timer saves time.&lt;/li&gt;
  &lt;li&gt;Focus on one element of practice at a time.&lt;/li&gt;
  &lt;li&gt;Try and practice a little every day, rather than practising a lot all on one day..&lt;/li&gt;
  &lt;li&gt;Keep track of your practice: use a practice schedule..&lt;/li&gt;
  &lt;li&gt;If it sounds good, it is good!&lt;/li&gt;
  &lt;li&gt;Playing and Practicing are very different, don’t confuse them.&lt;/li&gt;
  &lt;li&gt;The more you think, the more you stink! Practice until it becomes instinctive.&lt;/li&gt;
&lt;/ol&gt;

&lt;h2 id=&quot;section-1&quot;&gt;乐理知识&lt;/h2&gt;

&lt;h3 id=&quot;section-2&quot;&gt;音符时值&lt;/h3&gt;

&lt;p&gt;定义：
	- 音符：西方音乐的基本元素，用来表示相对长度的固定音高单位。
	- 时值：音符的相对持续时间&lt;/p&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;音符&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;时值（四分音符=1拍）&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;五线谱符号&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;简谱符号（X为任意音）&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;全音符&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;4&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;img src=&quot;/images/Whole_note.gif&quot; alt=&quot;&quot; /&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;code class=&quot;highlighter-rouge&quot;&gt;X---&lt;/code&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;二分音符&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;2&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;img src=&quot;/images/Half_note.gif&quot; alt=&quot;&quot; /&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;code class=&quot;highlighter-rouge&quot;&gt;X-&lt;/code&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;四分音符&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;1&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;img src=&quot;/images/Quarter_note.gif&quot; alt=&quot;&quot; /&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;code class=&quot;highlighter-rouge&quot;&gt;X&lt;/code&gt;&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;八分音符&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;0.5（半拍）&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;img src=&quot;/images/Eighth_note.gif&quot; alt=&quot;&quot; /&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;code class=&quot;highlighter-rouge&quot;&gt;&lt;u&gt;X&lt;/u&gt;&lt;/code&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;h3 id=&quot;section-3&quot;&gt;音&lt;/h3&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;音名&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;唱名&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;简谱&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;近似频率(Hz)&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;C&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;do&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;1&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;262&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;D&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;re&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;2&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;294&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;E&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;mi&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;3&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;330&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;F&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;fa&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;4&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;349&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;G&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;sol&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;5&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;392&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;A&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;la&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;6&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;440&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;B&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;si&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;7&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;494&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;h3 id=&quot;section-4&quot;&gt;音阶&lt;/h3&gt;
&lt;ol&gt;
  &lt;li&gt;十二平均律（又称十二等程律）：一种音乐的定律方法，将一个八度平均分成十二等份，每等分称为半音，是最主要的调音法。&lt;/li&gt;
  &lt;li&gt;全音和半音：&lt;/li&gt;
&lt;/ol&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;序号&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;自然音&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;以升表示（符号）&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;以降表示（符号）&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;1&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;C&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;2&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;C#&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Db&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;3&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;D&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;4&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;D#&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Eb&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;5&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;E&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;6&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;F&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;7&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;F#&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Gb&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;8&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;G&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;9&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;G#&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Ab&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;10&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;A&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;11&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;A#&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Bb&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;12&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;B&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;h3 id=&quot;section-5&quot;&gt;拍号&lt;/h3&gt;

&lt;p&gt;分母表示拍子的时值，分子代表每一小节有多少拍子。&lt;code class=&quot;highlighter-rouge&quot;&gt;3/4&lt;/code&gt;叫四三拍，表示四分音符为一拍，每个小节有三拍。&lt;/p&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;拍号&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;强弱关系&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;3/4&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;强-弱-弱&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;4/4&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;强-弱-次强-弱&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;h3 id=&quot;section-6&quot;&gt;吉他空弦&lt;/h3&gt;

&lt;p&gt;从上到下：&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;6弦：低音mi（E）&lt;/li&gt;
  &lt;li&gt;5弦：低音la（A）&lt;/li&gt;
  &lt;li&gt;4弦：re（D）&lt;/li&gt;
  &lt;li&gt;3弦：sol（G）&lt;/li&gt;
  &lt;li&gt;2弦：si（B）&lt;/li&gt;
  &lt;li&gt;1弦：高音mi（E）&lt;/li&gt;
&lt;/ul&gt;

&lt;h3 id=&quot;mi&quot;&gt;mi指型&lt;/h3&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt; &lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;6弦&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;5弦&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;4弦&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;3弦&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;2弦&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;1弦&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;空弦&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;E&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;A&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;D&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;G&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;B&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;E&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;1品&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;F&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;C&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;F&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;2品&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;B&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;E&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;A&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;3品&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;G&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;C&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;F&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt; &lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;D&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;G&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;h3 id=&quot;section-7&quot;&gt;音程&lt;/h3&gt;

&lt;ul&gt;
  &lt;li&gt;
    &lt;p&gt;定义1：两个音在音高上的距离叫做“音程”，计量单位为“度”。&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;举例：1-1（do-do）为一度，也叫同度；1-2（do-re）为两度；1-3（do-mi）为三度。&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;定义2：中间含有半音的为“大n度”，中间不含半音的为“小n度”。&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;举例：1-3为“大三度”，3-5为“小三度”&lt;/p&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h3 id=&quot;section-8&quot;&gt;和弦&lt;/h3&gt;

&lt;p&gt;定义：一种音的组合，至少三个组成，按照3度关系排列起来，叫做和弦。&lt;/p&gt;

&lt;p&gt;举例：Em：根音为E（mi），3-5（mi-sol）为小三度，5-7（sol-si）为大三度。先是小三度，后是大三度称为minor。&lt;/p&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;Em&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt; &lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;7(si)&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;五音&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;5(sol)&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;三音&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;3(mi)&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;根音&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;h2 id=&quot;section-9&quot;&gt;有用的链接&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;https://www.coursera.org/learn/guitar/&quot;&gt;《Introduction to Guitar》 on Coursera&lt;/a&gt;&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;&lt;a href=&quot;http://www.justinguitar.com/en/BC-000-BeginnersCourse.php&quot;&gt;《Justin’s Beginners Guitar Course》&lt;/a&gt;&lt;/p&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;section-10&quot;&gt;常见和弦&lt;/h2&gt;

&lt;h3 id=&quot;em&quot;&gt;Em&lt;/h3&gt;

&lt;p&gt;E/mi/3 - G/sol/5 - B/si/7&lt;/p&gt;

&lt;p&gt;E - B - E - G - B - E&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_Em.jpg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;

&lt;h3 id=&quot;am&quot;&gt;Am&lt;/h3&gt;

&lt;p&gt;A/la/6 - C/do/1 - E/mi/3&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_Am.jpg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;

&lt;h3 id=&quot;c&quot;&gt;C&lt;/h3&gt;

&lt;p&gt;C/do/1 - E/mi/3 - G/sol/5&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_C.jpg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;

&lt;h3 id=&quot;dm&quot;&gt;Dm&lt;/h3&gt;

&lt;p&gt;D/re/2 - F/fa/4 - A/la/6&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_Dm.jpg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;

&lt;h3 id=&quot;g&quot;&gt;G&lt;/h3&gt;

&lt;p&gt;G/sol/5 - B/si/7 - D/re/2&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_G.jpg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;

&lt;h3 id=&quot;fmaj7&quot;&gt;Fmaj7&lt;/h3&gt;

&lt;p&gt;F/fa/4 - A/la/6 - C/do/1 - E/mi/3&lt;/p&gt;

&lt;p&gt;（从4到3，7度；大三度 - 小三度 –&amp;gt; 大和弦； 大和弦 - 大三度 –&amp;gt; major）&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_Fmaj7.jpg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;

&lt;h3 id=&quot;d&quot;&gt;D&lt;/h3&gt;

&lt;p&gt;D/re/2 - F#/fa/4 - A/la/6&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_D.jpeg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;

&lt;h3 id=&quot;am7&quot;&gt;Am7&lt;/h3&gt;

&lt;p&gt;A/la/6 - C/do/1 - E/mi/3 - G/sol/5&lt;/p&gt;

&lt;p&gt;（小三度 - 大三度 –&amp;gt; 小和弦； 小和弦 - 小三度 –&amp;gt; minor）&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_Am7.jpeg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;

&lt;h3 id=&quot;bm&quot;&gt;Bm&lt;/h3&gt;

&lt;p&gt;B/si/7 - D/re/2 - F/fa/4&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/guitar_chord_Bm.jpeg&quot; alt=&quot;&quot; style=&quot;width: 250px; display:block; margin: 0 auto;&quot; /&gt;&lt;/p&gt;
</description>
        <pubDate>Sun, 11 Sep 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/09/11/music_knowledge.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/09/11/music_knowledge.html</guid>
        
        <category>music</category>
        
        
      </item>
    
      <item>
        <title>HTTP请求和返回示例</title>
        <description>&lt;p&gt;以GeneDock官网（&lt;a href=&quot;https://genedock.com&quot;&gt;https://genedock.com&lt;/a&gt;）为例，用各种软件（curl，HTTPie，Postman REST Client，python的request）进行请求和返回。&lt;/p&gt;

&lt;h2 id=&quot;curl&quot;&gt;Curl&lt;/h2&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;$curl -v https://genedock.com


* Rebuilt URL to: https://genedock.com/
*   Trying 182.92.0.168...
* Connected to genedock.com (182.92.0.168) port 443 (#0)
* TLS 1.2 connection using TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
* Server certificate: *.genedock.com
* Server certificate: RapidSSL SHA256 CA - G3
* Server certificate: GeoTrust Global CA
&amp;gt; GET / HTTP/1.1
&amp;gt; Host: genedock.com
&amp;gt; User-Agent: curl/7.43.0
&amp;gt; Accept: */*
&amp;gt;
&lt;span class=&quot;nt&quot;&gt;&amp;lt; HTTP&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;/&lt;/span&gt;&lt;span class=&quot;na&quot;&gt;1&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;na&quot;&gt;1&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;200&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;OK&lt;/span&gt;
&lt;span class=&quot;err&quot;&gt;&amp;lt;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Server:&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;nginx&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;/&lt;/span&gt;&lt;span class=&quot;na&quot;&gt;1&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;na&quot;&gt;6&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;na&quot;&gt;0&lt;/span&gt;
&lt;span class=&quot;err&quot;&gt;&amp;lt;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Date:&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Mon&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;05&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Sep&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;2016&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;05:58:07&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;GMT&lt;/span&gt;
&lt;span class=&quot;err&quot;&gt;&amp;lt;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Content-Type:&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;text&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;/&lt;/span&gt;&lt;span class=&quot;na&quot;&gt;html&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;charset=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;utf-8&lt;/span&gt;
&lt;span class=&quot;err&quot;&gt;&amp;lt;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Content-Length:&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;8856&lt;/span&gt;
&lt;span class=&quot;err&quot;&gt;&amp;lt;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Connection:&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;keep-alive&lt;/span&gt;
&lt;span class=&quot;err&quot;&gt;&amp;lt;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Set-Cookie:&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;session=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;eyJfaWQiOnsiIGIiOiJaREZsWm1ObU16UTFabVJtWlRSa016ZGlabU5rWldWaU5qWmpPVFJoTTJJPSJ9fQ.Cq6a7w.LUjBEmjf-e6B_4aGSpSHElVIVzg;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;HttpOnly&lt;/span&gt;&lt;span class=&quot;err&quot;&gt;;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;Path=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;/&lt;/span&gt;
&lt;span class=&quot;err&quot;&gt;&amp;lt;&lt;/span&gt;
&lt;span class=&quot;err&quot;&gt;&amp;lt;!&lt;/span&gt;&lt;span class=&quot;na&quot;&gt;DOCTYPE&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;html&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;gt;&amp;lt;html&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;lang=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;zh-CN&quot;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;gt;&amp;lt;head&amp;gt;&amp;lt;title&amp;gt;&lt;/span&gt;GeneDock&lt;span class=&quot;nt&quot;&gt;&amp;lt;/title&amp;gt;&amp;lt;meta&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;charset=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;utf-8&quot;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;gt;&amp;lt;meta&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;content=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;IE=edge&quot;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;http-equiv=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;X-UA-Compatible&quot;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;gt;&amp;lt;meta&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;content=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;width=1200&quot;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;name=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;viewport&quot;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;gt;&amp;lt;meta&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;content=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;GeneDock,www.genedock.com,genedock.com,genedock,北京聚道,聚道科技,基因数据云服务,北京聚道科技有限公司,GeneDock,北京GeneDock&quot;&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;name=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;Keywords&quot;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;gt;&amp;lt;meta&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;content=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;GeneDock,www.genedock.com,genedock.com,genedock,北京聚道,聚道科技,基因数据云服务,北京聚道科技有限公司,GeneDock,北京GeneDoc
......
&lt;/span&gt;&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

&lt;p&gt;&lt;code class=&quot;highlighter-rouge&quot;&gt;-v&lt;/code&gt;参数显示整个http通信过程。更多可以参考&lt;a href=&quot;http://www.ruanyifeng.com/blog/2011/09/curl.html&quot;&gt;阮一峰博客《curl网站开发指南》&lt;/a&gt;。&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;请求部分：&lt;/li&gt;
&lt;/ul&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;&amp;gt; GET / HTTP/1.1
&amp;gt; Host: genedock.com
&amp;gt; User-Agent: curl/7.43.0
&amp;gt; Accept: */*
&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

&lt;p&gt;&lt;code class=&quot;highlighter-rouge&quot;&gt;GET&lt;/code&gt;是http动词，&lt;code class=&quot;highlighter-rouge&quot;&gt;HTTP/1.1&lt;/code&gt;是HTTP的版本，&lt;code class=&quot;highlighter-rouge&quot;&gt;Host&lt;/code&gt;是服务端的主机，&lt;code class=&quot;highlighter-rouge&quot;&gt;User-Agent&lt;/code&gt;是发送请求的应用名称，&lt;code class=&quot;highlighter-rouge&quot;&gt;Accept&lt;/code&gt;是可以接受何种类型的返回。&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;返回部分：&lt;/li&gt;
&lt;/ul&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;&amp;lt; HTTP/1.1 200 OK
&amp;lt; Server: nginx/1.6.0
&amp;lt; Date: Mon, 05 Sep 2016 05:58:07 GMT
&amp;lt; Content-Type: text/html; charset=utf-8
&amp;lt; Content-Length: 8856
&amp;lt; Connection: keep-alive
&amp;lt; Set-Cookie: session=eyJfaWQiOnsiIGIiOiJaREZsWm1ObU16UTFabVJtWlRSa016ZGlabU5rWldWaU5qWmpPVFJoTTJJPSJ9fQ.Cq6a7w.LUjBEmjf-e6B_4aGSpSHElVIVzg; HttpOnly; Path=/
&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

&lt;p&gt;&lt;code class=&quot;highlighter-rouge&quot;&gt;200&lt;/code&gt;是status code（状态码），&lt;code class=&quot;highlighter-rouge&quot;&gt;Server&lt;/code&gt;是客户端应用软件的名字和版本号，&lt;code class=&quot;highlighter-rouge&quot;&gt;Date&lt;/code&gt;是消息产生的时间或者时间戳，&lt;code class=&quot;highlighter-rouge&quot;&gt;Content-Type&lt;/code&gt;是返回body的对象类型，&lt;code class=&quot;highlighter-rouge&quot;&gt;Content-Length&lt;/code&gt;是返回body的长度或者大小，&lt;code class=&quot;highlighter-rouge&quot;&gt;Connection&lt;/code&gt;是允许客户端和服务端指定请求-返回链接的选项，&lt;code class=&quot;highlighter-rouge&quot;&gt;Set-Cookie&lt;/code&gt;是用来设置客户端的一个token，让服务端来识别身份。&lt;/p&gt;

&lt;p&gt;返回的body部分是一个html文件。&lt;/p&gt;

&lt;h2 id=&quot;httpie&quot;&gt;HTTPie&lt;/h2&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;$http --print=HhBb https://genedock.com


GET / HTTP/1.1
Accept: */*
Accept-Encoding: gzip, deflate
Connection: keep-alive
Host: genedock.com
User-Agent: HTTPie/0.9.3



HTTP/1.1 200 OK
Connection: keep-alive
Content-Encoding: gzip
Content-Type: text/html; charset=utf-8
Date: Mon, 05 Sep 2016 06:34:50 GMT
Server: nginx/1.6.0
Set-Cookie: session=eyJfaWQiOnsiIGIiOiJZbUk1T0dReVpqbGhaakU0WkdObU1UazJaV05rTW1Fd05qVmtOakUzWW1ZPSJ9fQ.Cq6jig.rBqTiAoOL8QJj68W06WNs8lxlSY; HttpOnly; Path=/
Transfer-Encoding: chunked

&lt;span class=&quot;cp&quot;&gt;&amp;lt;!DOCTYPE html&amp;gt;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;lt;html&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;lang=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;zh-CN&quot;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;gt;&amp;lt;head&amp;gt;&amp;lt;title&amp;gt;&lt;/span&gt;GeneDock&lt;span class=&quot;nt&quot;&gt;&amp;lt;/title&amp;gt;&lt;/span&gt;
....
&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

&lt;p&gt;更多httpie的参数可见&lt;a href=&quot;https://github.com/jkbrzt/httpie&quot;&gt;https://github.com/jkbrzt/httpie&lt;/a&gt;&lt;/p&gt;

&lt;h2 id=&quot;postman-rest-client&quot;&gt;Postman REST Client&lt;/h2&gt;

&lt;p&gt;&lt;img src=&quot;/images/Postman-1.png&quot; alt=&quot;&quot; /&gt;&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/Postman-2.png&quot; alt=&quot;&quot; /&gt;&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/Postman-3.png&quot; alt=&quot;&quot; /&gt;&lt;/p&gt;

&lt;h2 id=&quot;pythonrequest&quot;&gt;Python的Request包&lt;/h2&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;$ python
Python 2.7.10 (default, Oct 23 2015, 19:19:21)
[GCC 4.2.1 Compatible Apple LLVM 7.0.0 (clang-700.0.59.5)] on darwin
Type &quot;help&quot;, &quot;copyright&quot;, &quot;credits&quot; or &quot;license&quot; for more information.

&amp;gt;&amp;gt;&amp;gt; import requests
&amp;gt;&amp;gt;&amp;gt; r = requests.get(&quot;https://genedock.com&quot;)
&amp;gt;&amp;gt;&amp;gt; print r.request.headers
{&#39;Connection&#39;: &#39;keep-alive&#39;, &#39;Accept-Encoding&#39;: &#39;gzip, deflate&#39;, &#39;Accept&#39;: &#39;*/*&#39;, &#39;User-Agent&#39;: &#39;python-requests/2.11.1&#39;}

&amp;gt;&amp;gt;&amp;gt; print r.headers
{&#39;Content-Encoding&#39;: &#39;gzip&#39;, &#39;Transfer-Encoding&#39;: &#39;chunked&#39;, &#39;Set-Cookie&#39;: &#39;session=eyJfaWQiOnsiIGIiOiJaakkzTnpZd09UQmtNRFEyWkdNM016a3paR0ZoWVRFNVpUWXhPVFJqWXprPSJ9fQ.Cq6lCQ.KzSeM-tEKnZxK8bvVi77qZSJnPQ; HttpOnly; Path=/&#39;, &#39;Server&#39;: &#39;nginx/1.6.0&#39;, &#39;Connection&#39;: &#39;keep-alive&#39;, &#39;Date&#39;: &#39;Mon, 05 Sep 2016 06:41:13 GMT&#39;, &#39;Content-Type&#39;: &#39;text/html; charset=utf-8&#39;}

&amp;gt;&amp;gt;&amp;gt; print r.status_code
200

&amp;gt;&amp;gt;&amp;gt; print r.content
&lt;span class=&quot;cp&quot;&gt;&amp;lt;!DOCTYPE html&amp;gt;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;lt;html&lt;/span&gt; &lt;span class=&quot;na&quot;&gt;lang=&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;zh-CN&quot;&lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&amp;gt;&amp;lt;head&amp;gt;&amp;lt;title&amp;gt;&lt;/span&gt;GeneDock&lt;span class=&quot;nt&quot;&gt;&amp;lt;/title&amp;gt;&lt;/span&gt;
&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

</description>
        <pubDate>Mon, 05 Sep 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/09/05/http_example.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/09/05/http_example.html</guid>
        
        <category>cs</category>
        
        
      </item>
    
      <item>
        <title>RESTful API</title>
        <description>&lt;h2 id=&quot;rest&quot;&gt;前言：什么是REST？&lt;/h2&gt;

&lt;blockquote&gt;
  &lt;p&gt;一种架构设计风格，提供了设计原则和约束条件，而不是架构。而满足这些约束条件和原则的应用程序或设计就是 RESTful架构或服务。&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;— &lt;a href=&quot;https://segmentfault.com/q/1010000003064904&quot;&gt;segmentfault&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;我理解“就是有了规范/规则/限制/风格”，就能享受到一些”好处“。&lt;/p&gt;

&lt;h2 id=&quot;overview&quot;&gt;Overview（概况）&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;REST: REpresentational State Transfer&lt;/li&gt;
  &lt;li&gt;Resource-based（基于资源）&lt;/li&gt;
  &lt;li&gt;Representations（表述）&lt;/li&gt;
  &lt;li&gt;Six constraints（6点限制）&lt;/li&gt;
  &lt;li&gt;Uniform Interface（统一接口）&lt;/li&gt;
  &lt;li&gt;Stateless（无状态性）&lt;/li&gt;
  &lt;li&gt;Cacheable（可缓存）&lt;/li&gt;
  &lt;li&gt;Client-Server（客户端-服务端结构）&lt;/li&gt;
  &lt;li&gt;Layered System（分层系统）&lt;/li&gt;
  &lt;li&gt;Code on Demand (optional)（按需编码）&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;resource-based&quot;&gt;Resource Based(基于资源)&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;Things vs. actions&lt;/li&gt;
  &lt;li&gt;Nouns vs. verbs&lt;/li&gt;
  &lt;li&gt;Versus SOAP-RPC（注：SOAP和RPC是另外两种主流的Web服务实现方案）&lt;/li&gt;
  &lt;li&gt;Identified by URIs
    &lt;ul&gt;
      &lt;li&gt;Multiple URIs may refer to same resource&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Separate from their representation(s)&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;representations&quot;&gt;Representations(表述)&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;How resources get manipulated（对资源的描述、如何操作资源的）&lt;/li&gt;
  &lt;li&gt;Part of the resource state
    &lt;ul&gt;
      &lt;li&gt;Transferred between client and server&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Typically JSON or XML&lt;/li&gt;
  &lt;li&gt;Example:
    &lt;ul&gt;
      &lt;li&gt;Resource: person(Todd)&lt;/li&gt;
      &lt;li&gt;Service: contact information (GET)&lt;/li&gt;
      &lt;li&gt;Representation:
        &lt;ul&gt;
          &lt;li&gt;name, address, phone number …&lt;/li&gt;
          &lt;li&gt;JSON or XML format&lt;/li&gt;
        &lt;/ul&gt;
      &lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;uniform-interface&quot;&gt;Uniform Interface（统一接口）&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;Defines the interface between client and server&lt;/li&gt;
  &lt;li&gt;Simplifies and decouples the architecture&lt;/li&gt;
  &lt;li&gt;Fundamental to RESTful design&lt;/li&gt;
  &lt;li&gt;For us this means:
    &lt;ul&gt;
      &lt;li&gt;HTTP verbs(GET, PUT, POST, DELETE)&lt;/li&gt;
      &lt;li&gt;URIs(resource name)&lt;/li&gt;
      &lt;li&gt;HTTP response(status, body)&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;stateless&quot;&gt;Stateless（无状态性）&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;Server contains no client state（服务端不包含任何客户端的状态）&lt;/li&gt;
  &lt;li&gt;Each request contains enough context to process the message（每一个请求都含有足够的内容来进行处理）
    &lt;ul&gt;
      &lt;li&gt;Self-descriptive messages（自明信息）&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Any session state is held on the client（任何的状态都由客户端来保存）&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;client-server-&quot;&gt;Client-Server（客户端-服务端结构）&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;Assume a disconnected system（假设两端不相连）&lt;/li&gt;
  &lt;li&gt;Separation of concerns（关注点分离）&lt;/li&gt;
  &lt;li&gt;Uniform interface is the link between the two（由统一接口将两者链接）&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;cacheable&quot;&gt;Cacheable（可缓存）&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;Server responses（representations）are cacheable（服务端的响应或者表述是可缓存的）
    &lt;ul&gt;
      &lt;li&gt;不准确地&lt;/li&gt;
      &lt;li&gt;准确地&lt;/li&gt;
      &lt;li&gt;可谈判地&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;layered-system&quot;&gt;Layered System（分层系统）&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;Client can’t assume direct connection to server&lt;/li&gt;
  &lt;li&gt;Software or hardware intermediaries between client and server&lt;/li&gt;
  &lt;li&gt;Improves scalability&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;code-on-demand&quot;&gt;Code on Demand（按需编码）&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;Server can temporarily extend client（服务端可以临时扩展客户端）&lt;/li&gt;
  &lt;li&gt;Transfer logic to client（将逻辑传给客户端）&lt;/li&gt;
  &lt;li&gt;Client executes logic（客户端来执行逻辑）&lt;/li&gt;
  &lt;li&gt;For example: Java applets; JavaScript&lt;/li&gt;
  &lt;li&gt;The only optional constraiant（唯一可选的）&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;summary&quot;&gt;Summary&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;Violating any constraint other than Code On Demand means service is not strictly RESTful（违反任何除“按需编码”之外的限制，都意味着服务不是严格地RESTful。注：目前REST-like也很流行）
    &lt;ul&gt;
      &lt;li&gt;Example: Three-legged OAUTH2&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Compliance with REST constraints allows（好处）:
    &lt;ul&gt;
      &lt;li&gt;Scalability&lt;/li&gt;
      &lt;li&gt;Simplicity&lt;/li&gt;
      &lt;li&gt;Modifiability&lt;/li&gt;
      &lt;li&gt;Visibility&lt;/li&gt;
      &lt;li&gt;Portability&lt;/li&gt;
      &lt;li&gt;Reliability&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;section&quot;&gt;参考资料：&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;&lt;a href=&quot;http://www.restapitutorial.com/lessons/whatisrest.html&quot;&gt;《What is REST》视频&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
</description>
        <pubDate>Sat, 03 Sep 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/09/03/REST.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/09/03/REST.html</guid>
        
        <category>cs</category>
        
        
      </item>
    
      <item>
        <title>换行符</title>
        <description>&lt;ul&gt;
  &lt;li&gt;windows: \r\n&lt;/li&gt;
  &lt;li&gt;unix: \n&lt;/li&gt;
&lt;/ul&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;sed -e &#39;s/$/\r/&#39; inputfile &amp;gt; outputfile                # UNIX to DOS  (adding CRs)
sed -e &#39;s/\r$//&#39; inputfile &amp;gt; outputfile                # DOS  to UNIX (removing CRs)
perl -pe &#39;s/\r\n|\n|\r/\r\n/g&#39; inputfile &amp;gt; outputfile  # Convert to DOS
perl -pe &#39;s/\r\n|\n|\r/\n/g&#39;   inputfile &amp;gt; outputfile  # Convert to UNIX
perl -pe &#39;s/\r\n|\n|\r/\r/g&#39;   inputfile &amp;gt; outputfile  # Convert to old Mac
&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

&lt;p&gt;参考： &lt;a href=&quot;http://stackoverflow.com/questions/6373888/converting-newline-formatting-from-mac-to-windows&quot;&gt;stackoverflow.com&lt;/a&gt;&lt;/p&gt;
</description>
        <pubDate>Fri, 02 Sep 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/09/02/line_break.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/09/02/line_break.html</guid>
        
        <category>cs</category>
        
        
      </item>
    
      <item>
        <title>http请求的工具</title>
        <description>&lt;h2 id=&quot;third-party-tools&quot;&gt;第三方软件（third-party tools）&lt;/h2&gt;

&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;软件&lt;/th&gt;
      &lt;th style=&quot;text-align: left&quot;&gt;描述&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;a href=&quot;http://curl.haxx.se/docs/manpage.html&quot;&gt;Curl&lt;/a&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Command line tool&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;a href=&quot;http://httpie.org/&quot;&gt;HTTPie&lt;/a&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Command line tool&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;a href=&quot;http://www.getpostman.com/&quot;&gt;Postman REST Client&lt;/a&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;App for Google Chrome and OS X&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;a href=&quot;http://restlet.com/products/dhc/&quot;&gt;DHC REST Client&lt;/a&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Google Chrome extension&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;&lt;a href=&quot;http://www.google.com/chrome/&quot;&gt;Google Chrome&lt;/a&gt;&lt;/td&gt;
      &lt;td style=&quot;text-align: left&quot;&gt;Google Chrome web browser&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;h2 id=&quot;python&quot;&gt;python的包&lt;/h2&gt;

&lt;ul&gt;
  &lt;li&gt;urllib2: Extensible library for opening URLs&lt;/li&gt;
  &lt;li&gt;urllib: Open arbitrary resources by URL&lt;/li&gt;
  &lt;li&gt;requests: HTTP for Humans, embedded urllib2 functionality&lt;/li&gt;
  &lt;li&gt;httplib2:This is a comprehensive HTTP client library. It supports features like
caching, keep-alive, compression, redirects and many kinds of authentication.&lt;/li&gt;
&lt;/ul&gt;

&lt;h2 id=&quot;section&quot;&gt;参考：&lt;/h2&gt;

&lt;p&gt;https://gdc-docs.nci.nih.gov/API/Users_Guide/Getting_Started&lt;/p&gt;
</description>
        <pubDate>Fri, 02 Sep 2016 00:00:00 +0800</pubDate>
        <link>zjuwhw.github.io/2016/09/02/http_tools.html</link>
        <guid isPermaLink="true">zjuwhw.github.io/2016/09/02/http_tools.html</guid>
        
        <category>cs</category>
        
        
      </item>
    
  </channel>
</rss>
